The effect of K201 on isolated working rabbit heart mechanical function during pharmacologically induced Ca 2+ overload

British Journal of Pharmacology

Volumn 165, Issue 4 B, 2012, Pages 1068-1083

  Kelly, A ^a   Elliott, E B ^a   Matsuda, R ^b   Kaneko, N ^c   Smith, G L ^a   Loughrey, C M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c Utsunomiya Memorial Hospital   (Japan)

Author keywords

adrenoceptor stimulation; isolated working heart; K201 (JTV 519); pressure volume catheter

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; BETA ADRENERGIC RECEPTOR; CALCIUM ION;

ADULT ANIMAL; ANIMAL TISSUE; AORTA FLOW; ARTICLE; CALCIUM CELL LEVEL; CALCIUM OVERLOAD; CALCIUM SIGNALING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; EXTRACELLULAR CALCIUM; HEART CONTRACTION; HEART FUNCTION; HEART LEFT VENTRICLE DP-DT; HEART PERFUSION; HEART PRELOAD; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE PRESSURE; ISOLATED HEART; MALE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR UPREGULATION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; CALCIUM; CARDIOTONIC AGENTS; HEART; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RABBITS; RECEPTORS, ADRENERGIC, BETA; THIAZEPINES;

EID: 84863011126     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01531.x     Document Type: Article

References (39)

1. Alexander SPH, Mathie A, Peters JA, (2011). Guide to Receptors and Channels (GRAC), 5th edn. Br J Pharmacol 164 (Suppl. 1): S1-S324.
2. 2+ release and contractions in isolated rat cardiomyocytes without increase in subsequent transient amplitude. J Biophys 487: 12 B331.
3. Ellison GM, Torella D, Karakikes I, Purushothaman S, Curcio A, Gasparri C, et al,. (2007). Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J Biol Chem 282: 11397-11409. (Pubitemid 47100807)
4. Fleckenstein A, Frey M, Fleckenstein-Grun G, (1983). Consequences of uncontrolled calcium entry and its prevention with calcium antagonists. Eur Heart J 4 (Suppl. H): 43-50. (Pubitemid 14211228)
5. Grieve DJ, Cave AC, Byrne JA, Layland J, Shah AM, (2004). Analysis of ex vivo left ventricular pressure-volume relations in the isolated murine ejecting heart. Exp Physiol 89: 573-582. (Pubitemid 39255729)
6. Hachida M, Lu H, Kaneko N, Nonoyama M, Koyanagi H, (1999). Protective effect of JTV519 on prolonged myocardial preservation. Transplant Proc 31: 1094. (Pubitemid 29127823)
7. Hasumi H, Matsuda R, Shimamoto K, Hata Y, Kaneko N, (2007). K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization. Eur J Pharmacol 555: 54-60. (Pubitemid 46013854)
8. 2+ release and [3H]ryanodine binding to RyR2 irrespective of FKBP12.6 association. Biochem J 404: 431-438. (Pubitemid 46953917)
9. 2+ overload in isolated rat hearts. Cardiovasc Drugs Ther 14: 489-495.
10. Ito KI, Shigematsu S, Sato T, Abe T, Li Y, Arita M, (2000). JTV-519, a novel cardioprotective agent, improves the contractile recovery after ischaemia-reperfusion in coronary perfused guinea-pig ventricular muscles. Br J Pharmacol 130: 767-776. (Pubitemid 30389055)
11. Joho S, Ishizaka S, Sievers R, Foster E, Simpson PC, Grossman W, (2007). Left ventricular pressure-volume relationship in conscious mice. Am J Physiol Heart Circ Physiol 292: 369-397.
12. Kaneko N, (1994). New 1,4-benzothiazepine derivative, K201, demonstrates cardio-protective effects against sudden cardiac cell death and intracellular calcium blocking action. Drug Dev Res 33: 429-438.
13. Kaneko N, Matsuda R, Chiwaki F, Hosoda S, (1994). Purification of cardiac annexin V from the beagle dog heart and changes in its localization in the ischemic rat heart. Heart Vessels 9: 148-154. (Pubitemid 24127420)
14. 2+ movement in large unilamellar vesicles by K201, a new 1,4-benzothiazepine derivative. Biochim Biophys Acta 1330: 1-7. (Pubitemid 27475261)
15. Kaneko N, Matsuda R, Nakajima T, Shinozaki T, Ohtani N, Oda K, et al,. (2006a). Norepinephrine-induced diastolic dysfunction with aortic valve opening under calcium-loading in rats. Drug Dev Res 67: 511-518. (Pubitemid 44621641)
16. Kaneko N, Matsuda R, Ohtani N, Nakajima T, Arikawa T, Suzuki H, et al,. (2006b). K201 improves norepinephrine-induced diastolic dysfunction with preserved ejection fraction. Drug Dev Res 67: 852-861.
17. Kashimura T, Briston SJ, Trafford AW, Napolitano C, Priori SG, Eisner DA, et al,. (2010). In the RyR2R4496C mouse model of CPVT, β-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves. Circ Res 107: 1483-1489.
18. Kass DA, Bronzwaer JG, Paulus WJ, (2004). What mechanisms underlie diastolic dysfunction in heart failure. Circ Res 94: 1533-1542. (Pubitemid 38856960)
19. Kawabata H, Ryomoto T, Ishikawa K, (2000). Effect of a novel cardioprotective agent, JTV-519, on metabolism, contraction and relaxation in the ischemia-reperfused rabbit heart. Jpn Circ J 64: 772-776.
20. Kawaguchi M, Hay I, Fetics B, Kass D, (2003). Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction. Circulation 107: 714-720.
21. Kimura J, Kawahara M, Sakai E, Yatabe J, Nakanishi H, (1999). Effects of a novel cardioprotective drug, JTV-519, on membrane currents of guinea pig ventricular myocytes. Jpn J Pharmacol 79: 275-281. (Pubitemid 29168136)
22. + current in guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol 361: 646-653. (Pubitemid 30350842)
23. Lederer WJ, Tsien RW, (1976). Transient inward current underlying arrhythmogenic effects of cardiotonic steroids in Purkinje fibres. J Physiol 263: 73-100. (Pubitemid 8014941)
24. Lisy O, Burnett JC Jr, (2006). New cardioprotective agent K201 is natriuretic and glomerular filtration rate enhancing. Circulation 113: 246-251.
25. max-end-diastolic volume relation in closed chest dogs. Circ Res 56: 808-815. (Pubitemid 15231503)
26. Liu N, Ruan Y, Priori SG, (2008). Catecholaminergic polymorphic ventricular tachycardia. Prog Cardiovasc Dis 51: 23-30. (Pubitemid 351965496)
27. 2+ release in normal adult rabbit ventricular cardiomyocytes. Cardiovasc Res 76: 236-246. (Pubitemid 350198587)
28. Miyata H, Lakatta EG, Stern MD, Silverman HS, (1992). Relation of mitochondrial and cytosolic free calcium to cardiac myocyte recovery after exposure to anoxia. Circ Res 71: 605-613.
29. Neely JR, Liebermeister H, Battersby EJ, Morgan HE, (1967). Effect of pressure development on oxygen consumption by isolated rat heart. Am J Physiol 212: 804-814.
30. Oda T, Yano M, Yamamoto T, Tokuhisa T, Okuda S, Doi M, et al,. (2005). Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 111: 3400-3410. (Pubitemid 40923393)
31. Pacher P, Nagayama T, Mukhopadhyay P, Batkai S, Kass DA, (2008). Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3: 1422-1434.
32. 2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation. Cardiovasc Res 87: 50-59.
33. Seidler T, Loughrey CM, Zibrova D, Kettlewell S, Teucher N, Kogler H, et al,. (2007). Overexpression of FK-506 binding protein 12.0 modulates excitation contraction coupling in adult rabbit ventricular cardiomyocytes. Circ Res 101: 1020-1029. (Pubitemid 350084979)
34. 2+ leak in intact ventricular myocytes from rabbits in heart failure. Circ Res 93: 592-594. (Pubitemid 37222154)
35. 2+ leak in failing hearts. Cardiovasc Res 81: 536-545.
36. 2+ transient amplitude in adult ventricular myocytes. Circ Res 98: 1299-1305. (Pubitemid 43948085)
37. Wallace A, Lam H-W, Mangano DT, (1995). Linearity, load dependence, hysteresis and clinical associations of systolic and diastolic indices of left ventricular function in man. J Card Surg 10: 460-467.
38. Wehrens XHT, Lehnart SE, Reiken S, van der Nagel R, Morales R, Sun J, et al,. (2005). Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc Natl Acad Sci USA 102: 9607-9612. (Pubitemid 40981728)
39. Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, et al,. (2003). FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107: 477-484. (Pubitemid 36158052)